The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) presents 2020 data and 2021 features of Wyoming’s Prescription Drug Monitoring Program (PDMP).
The acronym of Wyoming’s PDMP is WORx. It is administered by the state’s Pharmacy Board. The email address is provided, along with the URLs of the main website and related websites for enrollment, query, data upload, and statistics. Contact information is provided for the Executive Director and the WORx Coordinator. In 2020, the state population was 577,719, and there were 3,660 DEA-registered prescribers and 125 DEA-registered dispensers. A total of 19 reports are available from the PDMP. Funding for 2021 is from licensing fees, controlled substance registration fees, and the regulatory board fund. There are four PDMP staff members, with one staff member assigned to each of four task categories defined as operational, technical, analytical/epidemiological, and “other.” Key dates are listed for significant events in the establishment and development of the PDMP. Access information is provided for statutes and rules pertinent to the responsibilities and policies of the PDMP. Seven “miscellaneous capabilities and policies” of the PDMP are listed. Prescriber, patient, and dispenser data are purged after 5 years, with an option to retain de-identified data. No training in the features and use of the PDMP is reported. Procedures are described for establishing a PDMP account. Law enforcement access to patient data requires an active investigation and written request. Criteria for a query are reported. Enrollment in the PDMP is required for prescribers and dispensers, and prescribers are required to use the PDMP. Veterinarians are required to enroll with the PDMP as data requesters. Data monitored or accessible pertain to drugs listed in Schedules II-V, with the authority to monitor other substances. Other PDMP data pertain to child welfare case information, reciprocity, drug court case information, naloxone/narcan dispensing, and fatal drug overdoses.
810 Seventh Street NW, Washington, DC 20531, United States